Poultry News
  • Production
    • Broiler Production
    • Ducks
    • Egg Production
    • Game
    • Hatching
    • Housing
    • Turkeys
  • Processing
  • Business & Politics
    • Business
    • Economics
    • EU & Politics
    • Marketing
    • People
    • Training & Education
  • Welfare
    • Environment
    • Food Safety
    • Vet & Medication
    • Welfare
  • Feed
  • Genetics
  • New Products
  • Magazines
    • August 2025
    • 2025 Poultry Health supplement
    • July 2025
    • 2025 National Egg and Poultry Awards finalists supplement
    • June 2025
    • 2025 Innovation supplement
    • May 2025
    • April 2025
    • March 2025
    • 2025 Feed and Nutrition supplement
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • 2024 Building for the Future supplement
    • August 2024
    • 2024 Poultry Health supplement
    • July 2024
    • 2024 National Egg and Poultry Awards finalists supplement
    • June 2024
    • 2024 Innovation supplement
    • Pig & Poultry Fair 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • Processing Equipment Supplement – Nov 2023
    • October 2023
    • Building Supplement – Sept 2023
    • September 2023
  • Jobs
    • Browse Jobs
    • Post a Job
    • Manage Jobs
  • Events
    • National Egg and Poultry Awards
    • Poultry Fair
    • Webinars
Twitter LinkedIn
  • FREE Email Newsletters
  • About Us
  • Advertise
  • Subscribe
  • Contact Us
Twitter LinkedIn
Podcast
Poultry News
  • Production
    • Broiler Production
    • Ducks
    • Egg Production
    • Game
    • Hatching
    • Housing
    • Turkeys
  • Processing
  • Business & Politics
    • Business
    • Economics
    • EU & Politics
    • Marketing
    • People
    • Training & Education
  • Welfare
    • Environment
    • Food Safety
    • Vet & Medication
    • Welfare
  • Feed
  • Genetics
  • New Products
  • Magazines
    1. August 2025
    2. 2025 Poultry Health supplement
    3. July 2025
    4. 2025 National Egg and Poultry Awards finalists supplement
    5. June 2025
    6. 2025 Innovation supplement
    7. May 2025
    8. April 2025
    9. March 2025
    10. 2025 Feed and Nutrition supplement
    11. February 2025
    12. January 2025
    13. December 2024
    14. November 2024
    15. October 2024
    16. September 2024
    17. 2024 Building for the Future supplement
    18. August 2024
    19. 2024 Poultry Health supplement
    20. July 2024
    21. 2024 National Egg and Poultry Awards finalists supplement
    22. June 2024
    23. 2024 Innovation supplement
    24. Pig & Poultry Fair 2024
    25. May 2024
    26. April 2024
    27. March 2024
    28. February 2024
    29. January 2024
    30. December 2023
    31. November 2023
    32. Processing Equipment Supplement – Nov 2023
    33. October 2023
    34. Building Supplement – Sept 2023
    35. September 2023
    Featured

    Poultry Business – August 2025 issue out now

    By Chloe RyanAugust 13, 2025
    Recent

    Poultry Business – August 2025 issue out now

    August 13, 2025

    2025 Poultry Health supplement out now

    August 13, 2025

    Poultry Business – July 2025 issue

    July 1, 2025
  • Jobs
    • Browse Jobs
    • Post a Job
    • Manage Jobs
  • Events
    • National Egg and Poultry Awards
    • Poultry Fair
    • Webinars
Twitter LinkedIn
Poultry News
Business

EC approves “strategic swap” between Merial and Boehringer Ingelheim

Colin LeyBy Colin LeyNovember 11, 20163 Mins Read
Facebook Twitter LinkedIn Email
Share
Facebook Twitter LinkedIn Email

The acquisition of the animal health business of Sanofi (Merial) of France by Boehringer Ingelheim (BI) of Germany has been approved by the European Commission (EC) under its formal merger regulation.

“The decision is conditional on the divestment of a number of animal health vaccines and pharmaceuticals,” said the EC in its official judgement statement.

“The proposed transaction leads to a combination of two key competitors in the development, manufacturing, marketing and sale of animal health products across the European Economic Area (EEA).

“Following a thorough market investigation, the Commission found that competition concerns arose in the area of biologicals and pharmaceuticals. The Commission identified several markets where BI and Merial’s products are in competition with each other, namely different types of porcine and bovine vaccines, as well as non-steroidal anti-inflammatory drugs (NSAID) in injectable forms and NSAID in tablets for horses.

“In these markets, the Commission found that either BI or Merial was a strong player in the market, while the other was either already competing or developing a product in order to do so. In view of these findings and the limited number of other players in the market, the Commission concluded that the elimination of one of the merging companies would harm competition for the supply of these products in Europe, with a risk of price increases and loss of quality of service and supply.

“The Commission found no competition concerns for pharmaceuticals other than NSAIDs and for feed supplements since the companies’ market positions are limited and important competitors will remain active on these markets.”

In order to address the Commission’s competition concerns, the two companies offered to divest a number of Merial’s marketed and pipeline products, including its existing vaccines Circovac, Progressis, Parvovax, Parvovurax and Mucossifa and pharmaceuticals Ketofen, Wellicox, Allevinix, Genixine, Equioxx Injectable and Equioxx Paste.

Given the specific nature of these products, and in particular the stability and the consistency of all production processes involved, the divestment includes the full transfer of production technology (antigens and finished products) to the purchaser. During the transfer, BI and Merial committed to provide the purchaser with full technical support and a transitional supply agreement.

To ensure the success of the production transfer and the effectiveness of the commitments it was necessary to identify a purchaser able to take over the divested products. BI committed to carry out the technology transfer to Ceva Santé Animale (Ceva). Ceva is an established company in the animal health sector with expertise and experience in the relevant production technologies and an established distribution and marketing network throughout Europe. This transaction will require separate merger approval from the relevant competition authorities.

After the investigation and following a market test, the Commission concluded that the commitments addressed the identified competition concerns. In particular, the companies proposed a suitable purchaser with strong capabilities and incentives to run the divested businesses successfully in the long term.

Share. Facebook Twitter LinkedIn Email
Previous ArticleNew vaccine launched to provide “longer salmonella protection”
Next Article Dutch officials issue new AI advice to poultry sector
Colin Ley

Read Similar Stories

Business

Imports soar into EU egg market as prices continue to rise

August 26, 20252 Mins Read
Business

EU poultry imports surge

August 26, 20252 Mins Read
Business

MHP takes controlling stake in Grupo UVESA

August 14, 20252 Mins Read
Latest News

Environment Agency refuses Cranswick permit for Norfolk farm redevelopment

September 3, 2025

NFU survey reveals ageing UK poultry housing

September 3, 2025

Chicken price rises fuels meat and poultry inflation in August

September 2, 2025
Sponsored Content

How can UK farmers make poultry profitable without losing welfare?

September 1, 2025

Precision Nutrition: A global approach to reducing broiler feed cost.

August 1, 2025
© 2024 MA Agriculture Ltd, a Mark Allen Group company

Privacy Policy | Cookies Policy | Terms & Conditions

  • Farmers Weekly
  • AA Farmer
  • Farm Contractor
  • Pig World

Type above and press Enter to search. Press Esc to cancel.